U.S. DES Use Will Stabilize At Already Lowered Rates, Physicians Suggest

Recommendations by an FDA advisory panel earlier this month will likely reinforce, but not amplify, already moderated usage patterns of drug-eluting stents in the U.S., doctors suggest

More from Archive

More from Medtech Insight